临床医学工程
臨床醫學工程
림상의학공정
Clinical Medical & Engineering
2015年
10期
1283-1284
,共2页
高通量血液透析%肺心病心力衰竭%疗效%安全性
高通量血液透析%肺心病心力衰竭%療效%安全性
고통량혈액투석%폐심병심력쇠갈%료효%안전성
High flux hemodialysis%Pulmonary heart disease complicating heart failure%Efficacy%Safety
目的：探讨高通量血液透析在肺心病心力衰竭中的应用价值。方法收集我院2014年7月至2015年8月收治的60例肺心病心力衰竭患者，随机分为两组各30例。对照组给予常规治疗，观察组在此基础上联合高通量血液透析治疗。比较两组的临床疗效、血气分析及肾功能指标等变化情况。结果治疗后观察组总有效率为96.67%，明显高于对照组的70.00%，差异有统计学意义(P＜0.01)；治疗后两组患者血气分析指标(PaO2、 PaCO2、 SaO2)均较治疗前明显改善，且观察组改善程度优于对照组(P＜0.01)；治疗后观察组肾功能指标(BUN、 Scr、β2-MG)及MMS均显著改善，明显优于对照组(P＜0.01)。结论在常规治疗基础上联合高通量血液透析治疗肺心病心力衰竭疗效显著，可有效改善患者的血气分析指标，安全性高，值得临床推广应用。
目的：探討高通量血液透析在肺心病心力衰竭中的應用價值。方法收集我院2014年7月至2015年8月收治的60例肺心病心力衰竭患者，隨機分為兩組各30例。對照組給予常規治療，觀察組在此基礎上聯閤高通量血液透析治療。比較兩組的臨床療效、血氣分析及腎功能指標等變化情況。結果治療後觀察組總有效率為96.67%，明顯高于對照組的70.00%，差異有統計學意義(P＜0.01)；治療後兩組患者血氣分析指標(PaO2、 PaCO2、 SaO2)均較治療前明顯改善，且觀察組改善程度優于對照組(P＜0.01)；治療後觀察組腎功能指標(BUN、 Scr、β2-MG)及MMS均顯著改善，明顯優于對照組(P＜0.01)。結論在常規治療基礎上聯閤高通量血液透析治療肺心病心力衰竭療效顯著，可有效改善患者的血氣分析指標，安全性高，值得臨床推廣應用。
목적：탐토고통량혈액투석재폐심병심력쇠갈중적응용개치。방법수집아원2014년7월지2015년8월수치적60례폐심병심력쇠갈환자，수궤분위량조각30례。대조조급여상규치료，관찰조재차기출상연합고통량혈액투석치료。비교량조적림상료효、혈기분석급신공능지표등변화정황。결과치료후관찰조총유효솔위96.67%，명현고우대조조적70.00%，차이유통계학의의(P＜0.01)；치료후량조환자혈기분석지표(PaO2、 PaCO2、 SaO2)균교치료전명현개선，차관찰조개선정도우우대조조(P＜0.01)；치료후관찰조신공능지표(BUN、 Scr、β2-MG)급MMS균현저개선，명현우우대조조(P＜0.01)。결론재상규치료기출상연합고통량혈액투석치료폐심병심력쇠갈료효현저，가유효개선환자적혈기분석지표，안전성고，치득림상추엄응용。
Objective To explore the application value of high flux hemodialysis in pulmonary heart disease complicating heart failure. Methods 60 patients with pulmonary heart disease complicating heart failure treated in our hospital from July 2014 to August 2015 were randomly divided into two groups, with 30 cases in each group. The control group was given conventional treatment, the observation group was given high-flux hemodialysis treatment on this basis. The clinical effect, changes of blood gas analysis (ABG) indices and renal function indices of the two groups were compared. Results After treatment, the total effective rate of the observation group was 96.67%, higher than 70.00%of the control group (P<0.01);after treatment, the ABG indices (including PaO2, PaCO2, SaO2) of the two groups were improved, and the improvement degree of the observation group was better than that of the control group (P <0.01); the renal function indicators (BUN, Scr,β2-MG) and MMS level of the observation group were improved, and better than those of the control group (P<0.01). Conclusions Routine treatment combined with high-flux hemodialysis has significant effect in treatment of pulmonary heart disease complicating heart failure, and can effectively improve the patients' ABG indices, which has high safety and deserves promotion in clinic.
